NCT00133848 - Treatment Of Impetigo With Topical SB-275833 Ointment, 1% Versus Topical Placebo Ointment | Biotech Hunter

Enrollment

210

Participants

Timeline

Start Date

April 30, 2005

Study Completion Date

January 31, 2006

Conditions

Impetigo

Interventions

DRUG

SB-275833 ointment, 1%

Trial Locations (22)

40000

GSK Investigational Site, Hyderabad

45190

GSK Investigational Site, Zapopan, Jalisco

560 054

GSK Investigational Site, Bangalore

00133

GSK Investigational Site, Rome

06780

GSK Investigational Site, Mexico City

5741 CG

GSK Investigational Site, Beek en Donk

5751 XJ

GSK Investigational Site, Deurne

3851 EX

GSK Investigational Site, Ermelo

2806 DA

GSK Investigational Site, Gouda

9581 AD

GSK Investigational Site, Musselkanaal

9581 AJ

GSK Investigational Site, Musselkanaal

6531 NB

GSK Investigational Site, Nijmegen

7442 LS

GSK Investigational Site, Nijverdal

2371 RB

GSK Investigational Site, Roelofarendsveen

3015 GE

GSK Investigational Site, Rotterdam

3082 DC

GSK Investigational Site, Rotterdam

6027 RN

GSK Investigational Site, Soerendonk

3443 GG

GSK Investigational Site, Woerden

7136 KH

GSK Investigational Site, Zieuwent

3331 LZ

GSK Investigational Site, Zwijndrecht

Callao 1

GSK Investigational Site, Callao

Lima 31

GSK Investigational Site, Lima